- Home
- CDE vs CPRX Comparison
CDE vs CPRX Comparison
Compare CDE & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDE
- CPRX
- Stock Information
- Founded
- CDE 1928
- CPRX 2002
- Country
- CDE United States
- CPRX United States
- Employees
- CDE N/A
- CPRX N/A
- Industry
- CDE Precious Metals
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CDE Basic Materials
- CPRX Health Care
- Exchange
- CDE Nasdaq
- CPRX Nasdaq
- Market Cap
- CDE 2.5B
- CPRX 2.5B
- IPO Year
- CDE N/A
- CPRX 2006
- Fundamental
- Price
- CDE $5.93
- CPRX $22.21
- Analyst Decision
- CDE Strong Buy
- CPRX Strong Buy
- Analyst Count
- CDE 4
- CPRX 7
- Target Price
- CDE $7.81
- CPRX $32.86
- AVG Volume (30 Days)
- CDE 9.4M
- CPRX 1.1M
- Earning Date
- CDE 02-19-2025
- CPRX 02-26-2025
- Dividend Yield
- CDE N/A
- CPRX N/A
- EPS Growth
- CDE N/A
- CPRX 114.68
- EPS
- CDE N/A
- CPRX 1.18
- Revenue
- CDE $1,010,652,000.00
- CPRX $460,482,000.00
- Revenue This Year
- CDE $32.61
- CPRX $23.98
- Revenue Next Year
- CDE $39.85
- CPRX $18.27
- P/E Ratio
- CDE N/A
- CPRX $18.84
- Revenue Growth
- CDE 31.38
- CPRX 32.17
- 52 Week Low
- CDE $2.42
- CPRX $13.12
- 52 Week High
- CDE $7.72
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- CDE 44.73
- CPRX 54.37
- Support Level
- CDE $5.53
- CPRX $19.15
- Resistance Level
- CDE $6.66
- CPRX $24.00
- Average True Range (ATR)
- CDE 0.26
- CPRX 0.99
- MACD
- CDE 0.04
- CPRX 0.10
- Stochastic Oscillator
- CDE 35.40
- CPRX 63.09
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.